Our people

Why Merck is well-positioned to tackle the COVID-19 pandemic

with Daria Hazuda, VP, infectious disease discovery and chief science officer

June 11, 2020

Share this article

article hero thumbnail

With more than 20 years of experience in drug discovery and development, Daria has made a number of important contributions to the field of infectious diseases, including leading the team that identified a new way to attack and treat HIV.

Daria Hazuda

Read the transcript.

Listen as Daria explains how Merck’s strong foundation in the research, development and manufacturing of novel vaccines and medicines will help as it works to create those needed to tackle the pandemic and why the company continues to invest in research to address antimicrobial resistance.